These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1375964)

  • 1. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.
    Shiosaki K; Lin CW; Kopecka H; Craig RA; Bianchi BR; Miller TR; Witte DG; Stashko M; Nadzan AM
    J Med Chem; 1992 May; 35(11):2007-14. PubMed ID: 1375964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.
    Shiosaki K; Lin CW; Kopecka H; Tufano MD; Bianchi BR; Miller TR; Witte DG; Nadzan AM
    J Med Chem; 1991 Sep; 34(9):2837-42. PubMed ID: 1716682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors.
    Shiosaki K; Lin CW; Kopecka H; Bianchi B; Miller T; Stashko M; Witte D
    J Med Chem; 1997 Mar; 40(7):1169-72. PubMed ID: 9089338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
    Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
    J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue.
    Bennett MJ; Nikkel AL; Bianchi BR; Miller TR; Bednarz L; Witte DG; Stashko M; Wang SS; Gore PA; Asin KE
    J Med Chem; 1994 May; 37(11):1569-71. PubMed ID: 8201591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
    J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
    Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
    J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
    Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
    J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetrapeptide CCK-A agonists: effect of backbone N-methylations on in vitro and in vivo CCK activity.
    Holladay MW; Kopecka H; Miller TR; Bednarz L; Nikkel AL; Bianchi BR; Witte DG; Shiosaki K; Lin CW; Asin KE
    J Med Chem; 1994 Mar; 37(5):630-5. PubMed ID: 8126703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists.
    Elliott RL; Kopecka H; Tufano MD; Shue YK; Gauri AJ; Lin CW; Bianchi BR; Miller TR; Witte DG; Stashko MA
    J Med Chem; 1994 May; 37(11):1562-8. PubMed ID: 8201590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A71378: a CCK agonist with high potency and selectivity for CCK-A receptors.
    Lin CW; Holladay MW; Witte DG; Miller TR; Wolfram CA; Bianchi BR; Bennett MJ; Nadzan AM
    Am J Physiol; 1990 Apr; 258(4 Pt 1):G648-51. PubMed ID: 2333977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity of C-terminal modified analogs of Ac-CCK-7.
    Tilley JW; Danho W; Shiuey SJ; Kulesha I; Sarabu R; Swistok J; Makofske R; Olson GL; Chiang E; Rusiecki VK
    Int J Pept Protein Res; 1992 Apr; 39(4):322-36. PubMed ID: 1385345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor.
    McCort-Tranchepain I; Ficheux D; Durieux C; Roques BP
    Int J Pept Protein Res; 1992 Jan; 39(1):48-57. PubMed ID: 1378822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).
    Sugg EE; Kimery MJ; Ding JM; Kenakin DC; Miller LJ; Queen KL; Rimele TJ
    J Med Chem; 1995 Jan; 38(1):207-11. PubMed ID: 7837233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
    Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
    Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues.
    Tilley JW; Danho W; Lovey K; Wagner R; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S
    J Med Chem; 1991 Mar; 34(3):1125-36. PubMed ID: 2002454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.
    Holladay MW; Bennett MJ; Tufano MD; Lin CW; Asin KE; Witte DG; Miller TR; Bianchi BR; Nikkel AL; Bednarz L
    J Med Chem; 1992 Aug; 35(16):2919-28. PubMed ID: 1501220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.